Media-OutReach Newswire Zuellig Pharma Strengthens Consumer Healthcare Portfolio with the Acquisition of Zam-Buk® and Vapex® Brands from Bayer
Natixis CIB bolsters key areas of expertise with senior leadership appointment in Australia & New Zealand 1.